Drug delays type 1 diabetes in people at high risk
June 9, 2019
A treatment affecting the immune system effectively slowed the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded research. The study is the first to show that clinical type 1 diabetes can be delayed by two or more years among people who are at high risk.
Read more
Reading level: Grade 12
EurekAlert!, the online, global news service operated by AAAS, the science society
Explore Our Science Videos
Build a Wind-Powered Car
Can You Kazoo?
Flying Helicopters on Mars - Paper Models